Detalhe da pesquisa
1.
A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab.
Future Oncol
; 19(33): 2213-2225, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589131